Skip to main content

Advertisement

SpringerLink
Log in

Biomarkers of Cardiac Disease in Duchenne Muscular Dystrophy are Insufficient in the Absence of Clinical Cardiologic and Neurologic Assessment

  • Letter To The Editor
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Anderson J, Seol H, Gordish-Dressman H, Hathout Y, Spurney CF (2017) CINRG investigators. interleukin 1 receptor-like 1 protein (ST2) is a potential biomarker for cardiomyopathy in duchenne muscular dystrophy. Pediatr Cardiol. https://doi.org/10.1007/s00246-017-1703-9

    Google Scholar 

  2. Finsterer J, Cripe L (2014) Treatment of dystrophin cardiomyopathies. Nat Rev Cardiol 11:168–179

    Article  CAS  PubMed  Google Scholar 

  3. Wettersten N, Maisel AS (2016) Biomarkers for heart failure: an update for practitioners of internal medicine. Am J Med 129:560–567

    Article  CAS  PubMed  Google Scholar 

  4. Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmuller H, Ginjaar HB, Aartsma-Rus AM, van Ommen GJ, den Dunnen JT, t Hoen PA (2011) Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 21:557–569

    Article  Google Scholar 

  5. Finsterer J, Gelpi E, Stöllberger C (2005) Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation. Acta Cardiol 60:445–448

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Krankenanstalt Rudolfstiftung, Juchgasse 25, 1030, Vienna, Austria

    Claudia Stöllberger & Josef Finsterer

  2. Vienna, Austria

    Claudia Stöllberger

Authors
  1. Claudia Stöllberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josef Finsterer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudia Stöllberger.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stöllberger, C., Finsterer, J. Biomarkers of Cardiac Disease in Duchenne Muscular Dystrophy are Insufficient in the Absence of Clinical Cardiologic and Neurologic Assessment. Pediatr Cardiol 39, 202–203 (2018). https://doi.org/10.1007/s00246-017-1790-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-017-1790-7

Search

Navigation